Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inmunotek Hellas is the Greek subsidiary of Inmunotek, a leading Spanish biopharmaceutical company dedicated to the research, development, and manufacturing of immunotherapy treatments. The company specializes in allergy and immunology, offering a range of diagnostic and therapeutic products including allergen-specific vaccines and mucosal bacterial vaccines. Their flagship products include Uromune, a sublingual spray for recurrent urinary tract infections, and Bactek for respiratory infections. Inmunotek Hellas operates as a commercial and medical hub, providing innovative immunological solutions to the Greek healthcare market. The company maintains a strong focus on personalized medicine through its tailored immunotherapy treatments for allergic diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inmunotek Hellas.